切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2012, Vol. 06 ›› Issue (01) : 9 -15. doi: 10.3877/cma.j.issn.1674-0807.2012.01.002

专家论坛

乳腺癌多学科综合治疗模式中手术治疗的核心作用
孙强1   
  1. 1.100730 北京,中国医学科学院北京协和医学院北京协和医院乳腺外科
  • 收稿日期:2011-11-07 出版日期:2012-02-01

Core role of surgery in multidisciplinary combined treatment for breast cancer

Qiang SUN   

  • Received:2011-11-07 Published:2012-02-01
引用本文:

孙强. 乳腺癌多学科综合治疗模式中手术治疗的核心作用[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(01): 9-15.

Qiang SUN. Core role of surgery in multidisciplinary combined treatment for breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2012, 06(01): 9-15.

[1]
Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010[J]. CA Cancer J Clin,2010,60(5):277-300.
[2]
王启俊, 祝伟星, 邢秀梅. 北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J]. 中华肿瘤杂志, 2006,28(3):208-210.
[3]
Rabinovitch R, Kavanagh B. Double Helix of breast cancer therapy:intertwining the Halsted and Fisher hypotheses[J]. J Clin Oncol,2009,27(15):2422-2423.
[4]
Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers[J]. J Clin Oncol, 1994, 12(10):2229-2234.
[5]
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503):2087-2106.
[6]
Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer[J]. N Engl J Med,2004,351(10):971-977.
[7]
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med,2002,347(16):1227-1232.
[8]
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002,347(16):1233-1241.
[9]
Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer[J]. N Engl J Med,2004,351(10):963-970.
[10]
Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27[J]. J Clin Oncol,2008,26(5):778-785.
[11]
Mathew J, Asgeirsson KS, Cheung KL, et al. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions[J]. Eur J Surg Oncol,2009,35(2):113-122.
[12]
Perloff M, Lesnick GJ, Korzun A, et al. Combination chemotherapy with mastectomy or radiotherapy for stage Ⅲbreast carcinoma: a Cancer and Leukemia Group B study[J]. J Clin Oncol,1988,6(2):261-269.
[13]
Tewari M, Krishnamurthy A, Shukla HS. Breast conservation in locally advanced breast cancer in developing countries:wise or waste[J]. Surg Oncol,2009,18(1):3-13.
[14]
沈松杰, 孙强. 复发转移性乳腺癌手术治疗进展[J]. 中华普通外科杂志,2011,26(8):706-708.
[15]
Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: incidence and outcomes[J]. J Am Coll Surg,2006,203(4):469-474.
[16]
Chagpar A, Meric-Bernstam F, Hunt KK, et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome[J]. Ann Surg Oncol,2003,10(6):628-634.
[17]
Pagani O, Senkus E, Wood W, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? [J]. J Natl Cancer Inst,2010,102(7):456-463.
[18]
Khan SA,Stewart AK,Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? [J]. Surgery,2002,132(4):620-626.
[19]
Gnerlich J, Jeffe DB, Deshpande AD, et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data[J]. Ann Surg Oncol,2007,14(8):2187-2194.
[20]
Soran A,Ozbas S,Kelsey SF,et al. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage Ⅳbreast cancer at the presentation (Protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases[J]. Breast J,2009,15(4):399-403.
[21]
Soran A. The impact of primary surgery on tumor progression in metastatic breast cancer (BC) patients:Protocol MF07-01 randomized study interim analysis[C]/ / 2010 Breast Cancer Symposium. Washington DC:American Society of Clinical Oncology,2010:93.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
阅读次数
全文


摘要